Biotech · Private company · Irvine, CA, US
Syntr Health Technologies, Inc.
Track this companyFree. Adds Syntr Health Technologies, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- SyntrFuge SystemFacial Atrophy and Loss of ContourClinicalTrials.gov · fetched Nov 12, 2026
- SyntrFuge SystemKnee OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
- Triamcinolone InjectionKnee OsteoarthritisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Knee OsteoarthritisNA · NOT_YET_RECRUITING · started Dec 1, 2027ClinicalTrials.gov NCT05526898 · fetched Nov 12, 2026
- Open Label, Multi-Center Study, Evaluating the Effect of Adipose Tissue Processed With the SyntrFuge™ System for Facial Fat GraftingNA · NOT_YET_RECRUITING · started Sep 1, 2026ClinicalTrials.gov NCT05522426 · fetched Nov 12, 2026
NIH awards7
- Prevention of Amputation with Rapid Healing of Diabetic Ulcers Using Autologous Microsized Fat TissueFiscal year 2026 · $313.4KNIH RePORTER 1R43DK147508-01 · fetched Nov 12, 2026
- Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue MicrosizingFiscal year 2026 · $1MNIH RePORTER 5R44TR004975-03 · fetched Nov 12, 2026
- Accelerating Bioengineering Approaches for Increasing Access to New Solutions Targeting Breast Cancer Reconstructive SurgeryFiscal year 2025 · $356.5KNIH RePORTER 1R43CA302403-01A1 · fetched Nov 12, 2026
- Rapid and Automated Dissociation of Tumor Tissue for Single Cell DiagnosticsFiscal year 2025 · $406.5KNIH RePORTER 1R43TR005720-01 · fetched Nov 12, 2026
- Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue MicrosizingFiscal year 2025 · $1.1MNIH RePORTER 2R44TR004975-02A1 · fetched Nov 12, 2026
- Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue MicrosizingFiscal year 2024 · $306.2KNIH RePORTER 1R43TR004975-01 · fetched Nov 12, 2026
- Device Automation of an FDA-cleared CD-Microfluidic Platform for Rapid Tissue MicrosizingFiscal year 2024 · $134.9KNIH RePORTER 3R43TR004975-01S1 · fetched Nov 12, 2026